Biotech Values

[poorgradstudent]

crou...

>You and Dew give some current examples that will not have 12 year protection but that is not the bulk of the business. Again, I fail to see how David Miller is wrong on that one...<

Generics try to rip each other apart trying to sell equivalent versions of drugs that sold 100 million a year when branded. You don't think that they'd have an equally insane drive to substitute for drugs that are selling billions per year just because they don't constitute the "bulk of the business"?